Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to (18)F–FDG-PET/CT

BACKGROUND: Gastro-intestinal stromal tumors (GISTs) are very rare tumors of the gastro-intestinal tract, originating from the interstitial cells of Cajal or a common cell precursor which both express type III tyrosine kinase receptors. Regorafenib is an oral multi-kinase inhibitor used to treat gas...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Van Weehaeghe, Donatienne, Gheysens, Olivier, Vandecaveye, Vincent, Schöffski, Patrick, Van Laere, Koen, Deroose, Christophe M.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5836457/
https://ncbi.nlm.nih.gov/pubmed/29506493
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4154-7
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki